Detection of rare thalassemia mutations using long-read single-molecule real-time sequencing
Fan Jiang,Ai-Ping Mao,Yin-Yin Liu,Feng-Zhi Liu,Yan-Lin Li,Jian Li,Jian-Ying Zhou,Xue-Wei Tang,Ai-Ping Ju,Fa-Tao Li,Jun-Hui Wan,Lian-Dong Zuo,Dong-Zhi Li
DOI: https://doi.org/10.1016/j.gene.2022.146438
IF: 3.913
2022-05-01
Gene
Abstract:Gap- polymerase chain reaction (PCR), reverse dot-blot assay (RDB), real-time PCR based multicolor melting curve analysis (MMCA assay), multiplex ligation-dependent probe amplification (MLPA) and Sanger sequencing are conventional methods to diagnose thalassemia but all of them have limitations. In this study, we applied single-molecule real-time (SMRT) sequencing following multiplex long-range PCR to uncover rare mutations in nine patients and their family members. The patients with different results between Gap-PCR and MMCA assay or with phenotype not matching genotype were included. Using SMRT sequencing, we first identified the carriers with αααanti3.7/HKαα, -α762bpα/αα (chr16:172,648-173,409), ααfusion/ααQS (in a trans configuration), two cases with novel gene rearrangements and another case with a novel 341bp insertion in α-globin gene cluster, respectively. One carrier with --SEA/αααanti4.2, and two carriers with the coexistence of globin variant and an α-globin gene duplication were also found. Most importantly, we could determine two defects in α-globin gene cluster being a cis or trans configuration in a single test. Our results showed that SMRT has great advantages in detection of α-globin gene triplications, rare deletions and determination of a cis or trans configuration. SMRT is a comprehensive and one-step method for thalassemia screening and diagnosis, especially for detection of rare thalassemia mutations.
genetics & heredity